Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CoSeal edges closer to Japanese sealant market:

This article was originally published in Clinica

Executive Summary

Cohesion Technologies has moved a step closer in its bid to market its CoSeal surgical sealant in Japan - the world's largest market for fibrin sealants. The firm's local distributor, Japan Lifeline, has submitted the product for approval several months ahead of plan, says Cohesion, of Palo Alto, California. Surgeons in Japan are already using in excess of $150 million in fibrin sealants annually, says Frank DeLustro, the company's president and chief operating officer. CoSeal, claimed to be the only completely synthetic vascular sealant, is already available in certain European countries and in Australia.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT072645

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel